Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CRYAB is compromised in pathologically affected oligodendrocytes in multiple system atrophy.

Brain pathology (Zurich, Switzerland)·2026

Same author

Reduced serum interleukin-2 associates with higher motor severity and along with CD4 T cell alterations may be an early event in isolated REM Sleep Behaviour Disorder.

Brain, behavior, & immunity - health·2026

Same author

Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease.

Human molecular genetics·2026

Same author

Location and mapping of the human rostromedial tegmental nucleus and associated midbrain inhibitory nuclei regulating dopamine neurons.

Brain structure & function·2026

Same author

Systemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum.

FEBS open bio·2026

Same author

Alpha-Synuclein in Neurodegeneration: From Shared Biology to Disease-Specific Phenotypes.

Cells·2026

Search research articles

Related Experiment Video

Updated: Apr 26, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

Longitudinal white matter changes in frontotemporal dementia subtypes.

Bonnie Y K Lam, Glenda M Halliday, Muireann Irish

Human Brain Mapping

|July 23, 2014

Summary

This summary is machine-generated.

This study reveals distinct white matter changes in frontotemporal dementia (FTD) subtypes over time. These changes differ from grey matter atrophy, offering insights into disease progression.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping

Published on: August 12, 2019

Related Experiment Videos

Last Updated: Apr 26, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping

Published on: August 12, 2019

Area of Science:

Neuroscience
Neurology
Radiology

Background:

Frontotemporal dementia (FTD) is a neurodegenerative disorder primarily affecting frontal and temporal lobes.
Longitudinal white matter (WM) changes and their relation to grey matter (GM) atrophy in FTD subtypes are not well understood.

Purpose of the Study:

To longitudinally track white matter integrity changes in behavioral-variant FTD (bvFTD), progressive non-fluent aphasia (PNFA), and semantic dementia (SD).
To compare these white matter changes with regional grey matter atrophy across FTD subtypes.

Main Methods:

Diffusion tensor imaging (DTI) and T1-weighted MRI scans were acquired at baseline and 12 months from 33 FTD patients (bvFTD, PNFA, SD) and 15 controls.
Tract-based spatial statistics (TBSS) analyzed white matter integrity (FA, MD, AD, RD).
Voxel-based morphometry (VBM) assessed grey matter atrophy patterns.

Main Results:

bvFTD showed initial orbitofrontal/anterior temporal WM changes progressing to posterior regions.
PNFA exhibited bilateral frontotemporal WM changes, with longitudinal progression favoring the right hemisphere.
SD presented with initial left temporal WM changes extending to bilateral frontotemporal tracts; GM atrophy progression was less pronounced across all subtypes.
Mean diffusivity (MD) detected baseline changes, while fractional anisotropy (FA) and radial diffusivity (RD) showed greater longitudinal changes.

Conclusions:

White matter changes demonstrate distinct patterns and progression across FTD subtypes.
Longitudinal WM integrity analysis provides valuable insights into FTD pathophysiology and disease progression.
Differences in diffusivity measures (MD vs. FA/RD) may reflect distinct pathological processes over time.